FOXO Technologies, Inc. ($FOXO) stock jumped about 58% on Thursday after the Minneapolis, Minnesota-based epigenetic biomarkers technology solutions company confirmed ...

FOXO Technologies Inc. has provided a shareholder update from its newly appointed CEO, Seamus Lagan, reflecting on recent achievements and outlining future plans. Following a significant change in ...

FOXO Technologies (FOXO) provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond ...

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment ...

MINNEAPOLIS, MN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold a special meeting of its shareholders at 10.30am EST on ...

FOXO Technologies (FOXO) will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday, January 17, 2025. Following the filing of its Definitive Proxy Statement ...

Epigenetics: FOXO Lab's., remains a pioneer in epigenetic biomarker discovery and commercialization. Our mission is to extend and enhance human life through advanced prognostics, therapeutic solutions ...

Short interest in FOXO Technologies Inc (AMEX:FOXO) decreased during the last reporting period, falling from 677.79K to 211.04K. This put 0.96% of the company's publicly available shares short.

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment ...